Pfizer Inc. (PFE): Price and Financial Metrics

PFE POWR Grades

• Value is the dimension where PFE ranks best; there it ranks ahead of 96.36% of US stocks.
• The strongest trend for PFE is in Stability, which has been heading up over the past 179 days.
• PFE's current lowest rank is in the Momentum metric (where it is better than 17.51% of US stocks).

PFE Stock Summary

• With a market capitalization of $256,821,218,780, PFIZER INC has a greater market value than 99.53% of US stocks.
• PFIZER INC's stock had its IPO on January 1, 1986, making it an older stock than 93.28% of US equities in our set.
• In terms of volatility of its share price, PFE is more volatile than just 9.52% of stocks we're observing.
• Stocks that are quantitatively similar to PFE, based on their financial statements, market capitalization, and price volatility, are LLY, MRK, ABBV, NVO, and BABA.
• PFE's SEC filings can be seen here. And to visit PFIZER INC's official web site, go to www.pfizer.com.

PFE Valuation Summary

• PFE's EV/EBIT ratio is 9.4; this is 12.96% lower than that of the median Healthcare stock.
• PFE's price/sales ratio has moved down 3.1 over the prior 243 months.

Below are key valuation metrics over time for PFE.

PFE Growth Metrics

Its 5 year net income to common stockholders growth rate is now at 155.39%.
• Its 3 year net cashflow from operations growth rate is now at 122.51%.
• Its year over year revenue growth rate is now at 107.75%.

PFE's revenue has moved up $39,328,000,000 over the prior 30 months.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-03-31	92,367	34,583	24,966
2021-12-31	81,288	32,580	21,979
2021-09-30	63,600	32,291	19,180
2021-06-30	51,637	23,552	13,228
2021-03-31	44,461	15,808	11,091
2020-12-31	41,908	14,403	9,616

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
• PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
• XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.